Next 10 |
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in p hysicians prescribing i nFoods more than doubled each quarter over the past 12 months. - Bio...
2024-04-15 00:53:47 ET More on Biomerica Financial information for Biomerica Read the full article on Seeking Alpha For further details see: Biomerica GAAP EPS of -$0.11, revenue of $1M
Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference in the DDW Irritable Bowel Syn...
Magna-Lab Inc. - Class A (YBGJ) is expected to report for quarter end 2023-12-31 Biomerica Inc. (BMRA) is expected to report for Q3 2024 EXPRESS INC. DL-01 (02Z0:DU) is expected to report $-8.99 for Q4 2024 Progressive Corporation (The) (PGR) is expected to report $3.18 for Q1 2024 ...
Collaborators at the University of Michigan will present new Data on InFoods ® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company at the forefront ...
IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, proudly announces the appointment of Gary Huff to its Strategic Advisory Board (SAB). Mr. Huff, former CEO of Diagnostics at Labo...
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built and ultimately managed the sale of the company for $1.53 billion IRVINE, Cali...
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023. Loss per shares narrows to $0.09 per share from $0.12 per share reflecting disciplined operating expense management. Company Received US FDA 510(k) Clearance f...
Aeon Co. Ltd. ADR (AONNY) is expected to report for Q3 2024 Wipro Limited (WIT) is expected to report $0.07 for Q3 2024 Biomerica Inc. (BMRA) is expected to report for Q2 2024 Auto Parts 4Less Group (FLES) is expected to report for quarter end 2023-10-31 Engie Brasil Energia S.A. ...
2023-12-20 08:36:29 ET Losers: Bluebird bio BLUE -52% on pricing of $125 million stock offering . Jin Medical International Ltd ( ZJYL ) -14% . Argen X SE ( ARGX ) -25% reports topline results from address study of Efgartigimod SC in Pemphigus . ...
News, Short Squeeze, Breakout and More Instantly...
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarter...
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in p hysicians prescribing i nFoods more than doubled each quarter over the past 12 months. - Bio...
Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference in the DDW Irritable Bowel Syn...